Garrido Pilar, Aldaz Azucena, Calleja Miguel Ángel, De Álava Enrique, Lamas María Jesús, Martín Miguel, Matías-Guiu Xavier, Palacios José, Vera Ruth
Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid.Hospital Virgen de las Nieves - Farmacia.
Servicio de Farmacia, Clínica Universidad de Navarra, Grupo de trabajo PkGen de la SEFH, Pamplona..
Farm Hosp. 2017 Nov 1;41(6):688-691. doi: 10.7399/fh.10877.
Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology (SEOM), Pathology (SEAP), and Hospital Pharmacy (SEFH) we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.
精准医学是一种新兴的疾病治疗和预防方法，它考虑到每个人在基因、环境和生活方式方面的个体差异。从概念和方法的角度来看，精准医学正在改变临床和生物医学研究以及医疗保健本身，为改善公众健康和降低医疗保健系统成本提供了绝佳机会。然而，精准医学的实施带来了伦理法律、监管、组织和知识相关的挑战。如果没有国家战略，无论如何都会实施的精准医学可能会在没有适当规划的情况下进行，而这种规划可以保证技术质量、所有公民平等获得最佳实践，从而侵犯患者和专业人员的权利，并危及医疗保健系统的偿付能力。通过西班牙医学肿瘤学会（SEOM）、病理学学会（SEAP）和医院药学学会（SEFH）发表的这篇论文，我们强调有必要在我国制定一项关于精准医学发展的共识性国家战略，回顾国内外背景，评论实施精准医学的机遇和挑战，并概述癌症精准医学国家战略的目标。
